SCHEMBL16625755

SCHEMBL16625755

c1ccc2c(c1)c1ncccc1n2-c1ccc2oc3ccc(-n4c5ccc(-n6c7ccccc7c7ncccc76)cc5c5ncccc54)cc3c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
NPC1 O15118 3/20 0.39
NCOA1 Q15788 1/20 0.35
PDE4D Q08499 3/20 0.34
KDM4E B2RXH2 7/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
ATM Q13315 1/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 2/20 0.33
RAB9A P51151 2/20 0.33
MPI P34949 1/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
USP2 O75604 2/20 0.31
HTT P42858 2/20 0.31
TP53 P04637 1/20 0.31
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16625763 0.97 MAPT (0.43) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL17264907 0.97 MAPT (0.43) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL4570442 0.97 MAPT (0.40) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL9890117 0.95 MAPT (0.39) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL16606294 0.94 MAPT (0.36) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL17264908 0.94 MAPT (0.36) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL9890376 0.93 MAPT (0.38) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL10348765 0.92 NPC1 (0.37) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL9890561 0.92 MAPT (0.36) MAPTNPC1NCOA1PDE4DKDM4E
SCHEMBL17264916 0.92 MAOA (0.35) MAPTNPC1NCOA1PDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190189932-A1 TRANSPARENT ELECTRODE AND ELECTRONIC DEVICE Konica Minolta, Inc. (JP) 2019-06-20 US disclosed
US-9941422-B2 Organic photoelectric conversion element and solar cell using the same Konica Minolta, Inc. (JP) 2018-04-10 US disclosed
US-9941422-B2 Organic photoelectric conversion element and solar cell using the same Konica Minolta, Inc. (JP) 2018-04-10 US disclosed
US-9882072-B2 Solar cell and transparent electrode Konica Minolta, Inc. (JP) 2018-01-30 US disclosed
US-9882072-B2 Solar cell and transparent electrode Konica Minolta, Inc. (JP) 2018-01-30 US disclosed
US-20160285008-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE Konica Minolta, Inc. (JP) 2016-09-29 US disclosed
US-20160285008-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE Konica Minolta, Inc. (JP) 2016-09-29 US disclosed
US-20150333272-A1 TRANSPARENT ELECTRODE, ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT ELEMENT Konica Minolta, Inc. (JP) 2015-11-19 US disclosed
US-20150096610-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL USING THE SAME SONY SEMICONDUCTOR SOLUTIONS CORPORATION (JP) 2015-04-09 US disclosed
US-20150096610-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL USING THE SAME SONY SEMICONDUCTOR SOLUTIONS CORPORATION (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160285008-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE EML4, L1CAM, OCIAD2 MAPT 1317/4885NPC1 2578/4885NCOA1 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.